Pediatric anesthesia & critical care

Hospital Volume and Noncardiac Surgery Outcomes for Patients With Congenital Heart Disease

J Cardiothorac Vasc AnesthPublished Retrospective database study

Main finding · In-hospital mortalityResult — go to the resultAdjusted odds ratio 1.14 95% CI 1.01–1.3

Authors' conclusion

In-hospital mortality is higher for patients with CHD undergoing noncardiac surgery at mid-volume centers; length of stay demonstrates a more variable pattern.

Study context

Population
Inpatients undergoing noncardiac procedures, Pediatric Health Information System (2016–2023)617,396 no congenital heart disease (CHD)
Participants
662,680 inpatients
Exposure
Hospital volume quintiles
Outcome
In-hospital mortality
Methodological detailsPediatric Health Information System database, multivariable analysis
  • Pediatric Health Information System database
  • Multivariable analysis

Main finding

As reported in the abstract

Adjusted odds ratio

1.14

95% CI 1.01–1.3

P = 0.034

By group

Quintile 3

0.83%

Quintile 3
aOR 1.14 (95% CI 1.01–1.3); P = 0.034
Mortality highest in quintile 3 among the full cohort
P < 0.001

Observational data: associations, not effects.

Further findings

Mortality, non-CHD cohort — Quintile 3
0.56%
Mortality, complex CHD cohort — Quintile 3
6.28%
Mortality, non-CHD cohort — Highest in quintile 3
p = 0.009
Mortality, complex CHD cohort — Highest in quintile 3
p = 0.024

In-hospital mortality, simple and single-ventricle lesions

Similar across quintiles

LOS

Longest LOS varied: quintile 3 (simple), quintile 1 (complex), quintiles 2 and 3 (single ventricle)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Hospital Volume and Noncardiac Surgery Outcomes for Patients With Congenital Heart Disease. J Cardiothorac Vasc Anesth. Published 8 October 2025. doi:10.1053/j.jvca.2025.10.009

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.